Verified Peptide ReviewLast reviewed: 2 April 2026
Compound Profile · GH Releasing
Tesamorelin
Tesamorelin is a synthetic GHRH analog. It has been approved in some jurisdictions for the reduction of excess abdominal fat in HIV-associated lipodystrophy.
LegalPrescriptionEvidenceStrongHuman useApproved
8.8/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Better-characterised than most GH-axis peptides thanks to FDA approval data, with a clearer safety and efficacy profile in its approved indication.
Reality check
What this isn't
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full Tesamorelin review
A stabilised GHRH analog that increases endogenous GH and IGF-1.
Approved by the FDA for HIV-associated lipodystrophy.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.